Erik Harris - Insider Trading & Ownership

Location
60 Leveroni Court, Novato, CA
Summary
The estimated net worth of Erik Harris is at least $4.24M dollars as of November 21, 2025. Erik Harris is the EVP & Chief Commercial Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $3.7M. Erik Harris is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $348K. Erik Harris is the Director of Rezolute, Inc. and owns shares of Rezolute, Inc. (RZLT) stock worth about $193K.
Signature
/s/ Erik Harris
All Insider Reports
All Insider Reports

Ownership of Erik Harris

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RARE Ultragenyx Pharmaceutical Inc. EVP & Chief Commercial Officer $3.7M -$636K -14.7% Mar 1, 2025
DNLI Denali Therapeutics Inc. Director $348K May 31, 2024
RZLT Rezolute, Inc. Director $193K Nov 19, 2025
INZY Inozyme Pharma, Inc. Director Oct 3, 2024

Insider Transactions Reported by Erik Harris:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.